Similar articles

• [Utility of beta-blockers in patients with ischemic heart disease undergoing non-cardiac surgery. Commentary].

  Escobar Cervantes C, Divisón JA, Seguí Díaz M. Escobar Cervantes C, et al. Semergen. 2014 Sep;40(6):343-4. doi: 10.1016/j.semerg.2014.05.016. Epub 2014 Jul 26. Semergen. 2014. PMID: 25074532 Spanish. No abstract available.
• Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.

  Andersson C, Mérie C, Jørgensen M, Gislason GH, Torp-Pedersen C, Overgaard C, Køber L, Jensen PF, Hlatky MA. Andersson C, et al. JAMA Intern Med. 2014 Mar;174(3):336-44. doi: 10.1001/jamainternmed.2013.11349. JAMA Intern Med. 2014. PMID: 24247428
• Perioperative β-blocker use: what is new in 2020?

  Wang X, Fernandez Robles C, Kertai MD. Wang X, et al. Curr Opin Anaesthesiol. 2020 Jun;33(3):417-422. doi: 10.1097/ACO.0000000000000853. Curr Opin Anaesthesiol. 2020. PMID: 32324663 Review.
• [Beta-blockers and non-cardiac surgery: benefit and risks].

  Schaal JV, Pelée de Saint Maurice G, Boutonnet M, Cottez-Gacia S, Ausset S. Schaal JV, et al. Ann Fr Anesth Reanim. 2009 Sep;28(9):806-7; author reply 807-8. doi: 10.1016/j.annfar.2009.07.071. Epub 2009 Aug 3. Ann Fr Anesth Reanim. 2009. PMID: 19651484 French. No abstract available.
• Effect of chronic beta-blockade on peri-operative outcome in patients undergoing non-cardiac surgery: an analysis of observational and case control studies.

  Giles JW, Sear JW, Foëx P. Giles JW, et al. Anaesthesia. 2004 Jun;59(6):574-83. doi: 10.1111/j.1365-2044.2004.03706.x. Anaesthesia. 2004. PMID: 15144298 Review.